Epista Life Science A/S

Legal form: Aktieselskab (A/S)
Status: Active
Established 29 April, 2009
Address: Slotsmarken 17, 2.th
2970 Hørsholm
Denmark

[email protected]

Phone: 48254500
Registration number: Registration 32141064

Past relations

Ultimate beneficial owners (UBOs): Klavs Esbjerg
2009-04-29 – 2022-05-31 39.59% ownership (2019-07-10 – 2022-05-31 ) 84.87% ownership (2009-04-29 – 2019-07-09 ) 77.63% voting rights (2019-07-10 – 2022-05-31 ) 84.87% voting rights (2009-04-29 – 2019-07-09 )
Legal owners: Enhance BidCo ApS 100% ownership (2022-05-31 – ) 100% voting rights (2022-05-31 – )

Bobby William Markosfalvi-Barabas Gray
2014-09-24 – 2022-05-31 5% ownership (2014-09-24 – 2022-05-31 ) 5% voting rights (2014-09-24 – 2022-05-31 )

Klavs Esbjerg Holding ApS 66.67% ownership (2021-12-20 – 2022-05-31 ) 66.67% voting rights (2021-12-20 – 2022-05-31 )

Pilmann Holding ApS 10% ownership (2021-12-20 – 2022-05-31 ) 10% voting rights (2021-12-20 – 2022-05-31 )

KLAVS ESBJERG HOLDING ApS 66.67% ownership (2014-09-24 – 2021-12-19 ) 66.67% voting rights (2014-09-24 – 2021-12-19 )

Nikolaj Hørup Vibede
2014-09-24 – 2016-01-01 5% ownership (2014-09-24 – 2016-01-01 ) 5% voting rights (2014-09-24 – 2016-01-01 )
Directors: Klavs Esbjerg
2009-04-29 –

Martin Woergaard
2009-04-29 – 2012-10-31
Board members: Klavs Esbjerg
2013-09-30 –

Katarína Larsen
2022-03-01 –

Line Hyldgaard Hjorth-Christensen
2022-09-05 –

Knut Ronny Christer Roos
2016-05-19 –

Ken Rasmussen
2013-09-30 – 2022-03-01

Mette Pilmann Esbjerg
2013-09-30 – 2016-05-19
Subsidiaries: GMP4Pharma ApS 100% ownership (2024-03-01 – 2024-10-31 ) 100% voting rights (2024-03-01 – 2024-10-31 )

Epista Life Science A/S has 112.00 full time equivalents (FTEs) and 116.00 employees as of 1 May, 2025.

Revenue

Profit/loss

'000	12-2012	12-2013	12-2014	12-2015	12-2016	12-2017
Currency	DKK	DKK	DKK	DKK	DKK	DKK
Revenue	0	0	0	0	0	0
Raw materials and consumables used	0	0	0	0	0	0
Other external expenses	0	0	0	0	0	0
Gross profit loss	7,785	10,852	16,153	20,393	19,906	23,721
Employee benefits expense	7,052	8,672	13,098	18,826	21,186	21,356
Wages and salaries	0	0	0	0	0	0
Depreciation amortisation expense and impairment losses of prop	0	0	0	0	0	0
Profit loss from ordinary operating activities	0	0	3,005	1,445	-1,401	2,244
Profit loss from ordinary activities before tax	643	2,073	3,186	1,682	-1,193	1,835
Other finance expenses	91	107	33	0	0	60
Tax expense	173	550	808	0	0	494
Profit loss	471	1,523	2,379	1,326	-884	1,341